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Leptospira interrogans glycolipoprotein (GLP) has been implicated in pathological and functional derange-
ment seen in leptospirosis. The goal of this study was to evaluate GLP’s ability to induce cellular activation,
as assessed by cytokine production and expression of surface activation markers. GLP extracted from either
pathogenic L. interrogans serovar Copenhageni or nonpathogenic Leptospira biflexa serovar Patoc (GLPp) was
used to stimulate peripheral blood mononuclear cell cultures from healthy donors. Supernatant cytokine levels
were measured by enzyme-linked immunosorbent assay. Expression of CD69 and HLA-DR on lymphocytes and
monocytes, as well as lipopolysaccharide (LPS) binding, were measured by flow cytometry. At 6 h of incubation,
GLP induced a significant rise in tumor necrosis factor alpha levels, which dropped progressively until 72 h
of incubation. Interleukin-10 peak levels were obtained at between 24 and 48 h, with sustained levels until 72 h
of incubation. The response magnitude was proportional to the GLP dose. CD69 expression on T lymphocytes
and monocytes increased significantly, as did HLA-DR expression on monocytes. GLPp induced no CD69 or
HLA-DR expression. GLP did not block biotinylated LPS binding to monocytes, suggesting that different
pathways are used to induce cell activation. In conclusion, GLP induces cellular activation and may play a
major role in the pathogenesis of leptospirosis.
Leptospirosis is a zooanthroponosis caused by pathogenic
spirochetes of the genus Leptospira. Infection due to those
microorganisms may either be nonsymptomatic or result in
different clinical pictures. The anicteric form is a flu-like dis-
ease with low morbidity but sometimes evolves to respiratory
failure or meningitis, resulting in death. The severe or icteric
form, also known as Weil’s syndrome, clinically resembles sep-
sis, with multiple organ dysfunction, mainly renal failure, acute
respiratory distress syndrome, coagulopathy, and shock with
hemodynamic alterations similar to hyperdynamic septic shock
(15, 24).
Like in classical bacterial sepsis of a different etiology,
plasma cytokine levels are elevated in severe leptospirosis (13).
In the acute phase, tumor necrosis factor alpha (TNF-) levels
rise and are associated with the severity of the disease (14, 39).
Interleukin-10 (IL-10) levels are also elevated but are not
associated with the severity of the disease. However, a high
IL-10/TNF- ratio is associated with a better prognosis, sug-
gesting that an anti-inflammatory response may be protective
(40).
Small-vessel vasculitis is the characteristic lesion found in
leptospirosis, leading to fluid and cell leakage and eventually to
severe hemorrhage. Tissue lesions are characterized by the
occurrence of major cellular damage in the presence of few
microorganisms, suggesting the involvement of toxic factors
from either the spirochete or the host, associated with bac-
terial-cellular adherence phenomena (5, 15, 29). Cytotoxic
activity of Leptospira interrogans cellular components was
demonstrated in the past (10, 32). The glycolipoprotein (GLP)
complex, extracted from L. interrogans by Tris-lysozyme treat-
ment followed by acetic acid precipitation, exerts toxic effects
through its lipid portion, leading to cell membrane perforation,
leakage of cell contents, and cell death (43). In rabbit renal
tubule epithelial cells, GLP inhibits sodium-potassium ATPase
(Na,K-ATPase) pump activity in a dose-dependent manner
(47). This may explain some electrolytic alterations observed in
leptospirosis patients with acute renal failure (1, 26, 36). In
experimental models with guinea pigs injected with pathogenic
L. interrogans, GLP can be detected in the damaged tissues
adhering to endothelial cells and to epithelial membranes,
accompanying other antigen deposits resulting from bacterial
destruction by the immune system (3, 25). Therefore, the GLP
complex may contain toxins potentially involved in the patho-
genesis of leptospirosis.
The objective of this work was to verify whether GLP ex-
tracted from either pathogenic or nonpathogenic Leptospira
was able to induce cellular activation, as assessed by cytokine
secretion and cell surface antigen expression.
MATERIALS AND METHODS
Toxins. The GLP complex was extracted from pathogenic L. interrogans sero-
var Copenhageni obtained from a patient with Weil’s syndrome and from non-
pathogenic Leptospira biflexa serovar Patoc (GLPp), using the method described
by Vihn et al. (43). Lipopolysaccharide (LPS) from Salmonella enterica serovar
Abortus Equi (kindly supplied by C. Galanos, Max Planck Institute für Immun-
biologie, Freiburg, Germany) was separated by the phenol-water method and
purified by the phenol-chloroform-petroleum ether method (17). Biotinylated
S. enterica serovar Abortus Equi LPS (LPSb) (kindly provided by M. Freunder-
berg, Max Planck Institute für Immunbiologie) was prepared by using the biotin
reagent biotinamidocaproate N-hydroxysuccinimide ester (Sigma, St. Louis,
Mo.) according to the instructions of the manufacturer.
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Blood collection and cell separation. For all experiments, 15 ml of peripheral
venous blood was collected from healthy volunteers in heparin-treated tubes and
5 ml was collected in dry tubes (Becton Dickinson, Franklin Lakes, N.J.). Pe-
ripheral blood mononuclear cells (PBMC) were obtained by the Ficoll gradient
method (Ficollpaque; Amersham Pharmacia Biotech, Uppsala, Sweden) and
suspended in RPMI 1640 medium (Sigma). The standard cell concentration was
2  106 cells/ml.
Cytokine kinetics and dose response. PBMC were cultivated in 300 l of
RPMI 1640 supplemented with 30 l of autologous serum in 24-well plates
(Nunclon; Nalge Nunc International, Roskilde, Denmark). Cells were stimulated
with 1 g of LPS per ml and 0.3, 0.03, and 0.003 g of GLP per ml. Supernatants
were collected after 6, 24, 48, and 72 h of incubation, and cells were discarded
after centrifugation at 6,500  g for 5 min. Cell-free supernatants were stored at
80°C until used for cytokine determination.
Measurement of cytokines. TNF- and IL-10 were measured by capture en-
zyme-linked immunosorbent assay (ELISA). Antibody pairs and reagents were
obtained from Genzyme (Cambridge, Mass.) for TNF- assays and from PharM-
ingen (San Diego, Calif.) for IL-10 assays. Samples were tested in duplicate, and
a standard curve with human recombinant cytokine was made in each plate. Tests
were performed according to the manufacturer’s instructions. The sensitivity was
5 pg/ml for TNF- and IL-10.
Induction of cell surface activation marker expression on lymphocytes and
monocytes. Cellular activation was performed by incubating 500 l of blood in
12- by 75-mm sterile tubes (Becton Dickinson Immunocytometry Systems
[BDIS]) for 6 h at 37°C and 5% CO2 with LPS at 1 g/ml, with GLP at 0.3 g/ml,
and without toxins as control. Monoclonal antibodies conjugated to fluoro-
chromes were used for surface staining of lymphocytes and monocytes. Mono-
clonal antibodies were the following: CD14-fluorescein isothiocyanate (FITC)
(BDIS), CD14-phycoerythrin (PE) (BDIS), CD69-FITC (PharMingen), HLA-
DR–PE (BDIS or PharMingen), CD8-perinidin cholorophyll protein (PerCP)
(BDIS), CD3-allophycocyanin (APC) (BDIS), murine immunoglobulin G1
(mIgG1)-FITC (PharMingen) and mIgG2a-PE (PharMingen). After incuba-
tion, 100 l of stimulated blood was distributed into four tubes containing the
following monoclonal antibodies: (i) mIgG1-FITC isotype for CD69, (ii) CD69-
FITC, (iii) mIgG2a-PE isotype for HLA-DR, and (iv) HLA-DR-PE. CD14-PE,
CD8-PerCP, and CD3-APC were added to tubes i and ii, and CD14-FITC was
added to tubes iii and iv, and the tubes were incubated at room temperature
(RT) in the dark for 15 min. After this procedure, 2 ml of phosphate-buffered
saline (PBS) was added to each tube, followed by centrifugation at 2,500  g for
5 min at 4°C. Supernatants were discarded, and cells were washed again with 2
ml of PBS and resuspended in 300 l of PBS–1% NaN3 (Sigma). Samples were
run in a FACSCalibur flow cytometer (BDIS). For each condition, 20,000 events
were acquired and analyzed using CellQuest software (BDIS). Lymphocyte ac-
quisition was accomplished using a forward- and side-scatter plot to establish a
gate over the low side scatter and low to moderate forward scatter. T-lymphocyte
subpopulations were identified using CD3 and CD8, where appropriate. CD3/
CD8 lymphocytes were considered T-cytotoxic and CD3/CD8 lymphocytes
were considered T-helper subpopulations. Monocytes were acquired using a
combination of side scatter and CD14 plotting. Expression of surface markers
was evaluated using dot plots or histograms.
Blockade of LPSb binding to its receptor by LPS or GLP. One hundred
microliters of blood was distributed in 12- by 75-mm tubes (BDIS) and incubated
at 37°C with 5% CO2 for 5 min in the presence of LPS or GLP. Both toxins were
used at increasing concentrations of 500, 5,000, and 10,000 ng/ml. After incuba-
tion, 5,000 ng of LPSb per ml was added and incubated for a further 5 min. As
a positive control for LPS binding, one tube was treated only with LPSb, and as
a negative control, one tube received neither toxins nor LPSb. Samples were then
washed with 2 ml of PBS, and tubes were centrifuged at 2,500  g for 5 min.
Supernatants were discarded, and cells were resuspended in 2 ml of lysis solution
(BDIS) and incubated for 15 min at RT in the dark. Next, tubes were centrifuged
at 2,500  g for 5 min and supernatants were discarded. Cells were washed with
2 ml of PBS and stained with CD14-FITC (BDIS) and streptavidin-APC (BDIS).
After incubation for 15 min at RT in the dark, cells were washed with 2 ml of PBS
and resuspended in 300 l of PBS–1% NaN3 (Sigma) for flow cytometry. The test
was performed as described above. Previous studies in our lab showed that
anti-CD14 monoclonal antibody (clone MP9) binding to CD14 molecules on
the monocyte surface was not influenced by the presence of LPS, even at con-
centrations of as high as 50,000 ng/ml (8).
Statistical analysis. One-way analysis of variance was used to compare GLP-
induced TNF- and IL-10 with those of controls, followed by post hoc analysis by
the Student-Neuman-Keuls method for all pairwise multiple comparisons. Ad-
herence to normality was tested with the Levene variance homogeneity test with
the Brown-Forsythe modification. Wilcoxon matched-pair tests were used to
compare GLP stimuli and controls in the flow cytometry experiments (CD69 and
HLA-DR expression on cell surfaces). The significance level was established as
5% in all analyses.
RESULTS
GLP-induced TNF- kinetics and dose response. Increasing
doses of GLP, from 0.003 to 0.3 g/ml, induced an evident
dose-response effect, which was detected at any incubation
time. GLP-induced TNF- secretion was already detected at
high levels as early as 6 h of incubation. At between 6 and 24 h
of incubation, TNF- remained stable, with a mild decrease
with 0.3 and 0.03 g/ml and a slight increase with 0.003 g/ml.
Progressively lower levels were observed at 48 and 72 h. LPS
produced similar kinetics, but TNF- peaked at 24 h (Fig. 1).
GLP-induced IL-10 kinetics and dose response. IL-10 secre-
tion was dose dependent but at lower levels than TNF- se-
cretion. IL-10 reached peak levels at between 24 and 48 h of
incubation with all doses and sustained a plateau until 72 h.
LPS induced a similar kinetics, but IL-10 peaked at 24 h,
decreasing thereafter (Fig. 2).
CD69 expression on lymphocytes and monocytes. After 6 h
of stimulation with 0.3 g of GLP per ml or 1 g of LPS per
ml, there was an increase in the surface expression of CD69, a
marker of cellular activation, in the CD3/CD8, CD3/
CD8, and CD14 subpopulations (Fig. 3). GLPp at the same
doses induced no lymphocyte or monocyte CD69 expression
(Fig. 3).
HLA-DR expression on monocytes. When stimulated with
0.3 g of GLP per ml, monocytes showed an increase in
HLA-DR surface expression, from a geometric mean fluores-
cence intensity ( standard deviation [SD]) of 224.19 104.55
to 767.73 126.40. GLPp at 0.3, 0.03, or 0.003 g/ml produced
no HLA-DR up-regulatory response. As expected, LPS in-
duced an increase in HLA-DR expression on monocytes (Fig.
4).
Lack of blockade of LPSb binding to its receptor by GLP.
LPS blocked binding of biotinylated LPS to monocytes at con-
centrations of 5,000 and 10,000 ng/ml. However, preincubation
with GLP led to no blocking effect at the same concentrations
(Fig. 5).
DISCUSSION
The results presented here demonstrated that GLP ex-
tracted from pathogenic L. interrogans serovar Copenhageni
induces cellular activation of PBMC. This was demonstrated
through the secretion of TNF- and IL-10 and the increase in
the expression of CD69 and HLA-DR markers for cellular
activation. It was also demonstrated that GLP extracted from
nonpathogenic L. biflexa serovar Patoc failed to induce cellular
activation under the same experimental conditions. These re-
sults also suggested that cellular activation induced by GLP
seems not to occur through the same LPS pathway, since the
former does not block LPSb binding to monocytes.
Leptospirosis is a toxin-mediated disease, in which toxins are
released by the spirochetes into the affected tissues (3, 4, 6).
From the pathology point of view, in addition to specific tissue
lesions, like interstitial nephritis and hepatic central-lobular
necrosis, a generalized vasculitis accompanied by hemorrhagic
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phenomena is seen in all tissues (24, 29). Few spirochetes can
be observed on the damaged tissue, strongly suggesting a toxic
nature of the disease process (3). Toxic vasculitis (5) could be
triggered by one or more factors that generate acute systemic
inflammation, which is clinically found in the most severe cases
such as in sepsis or systemic inflammatory response syndrome
of infectious origin. Among the many antigens isolated from
pathogenic Leptospira, GLP is likely to be involved in the
pathogenesis of the disease, as demonstrated by the blocking of
the tubular epithelial cell sodium pump in the kidneys (47).
This may be one of the mechanisms of renal dysfunction that
is characteristic of the disease (36). Other toxic effects exerted
by GLP may be observed in cultures of Vero and L929 cells,
leading to cell membrane perforations followed by cell death
(43). The presence of GLP in damaged tissues of patients and
experimental animals further supports the role of this molecule
in leptospirosis (25, 33).
In this study it was demonstrated that GLP could induce in
vitro and ex vivo lymphocyte and monocyte activation, leading
to cytokine secretion and membrane antigen expression of
activation markers. GLP induced TNF- secretion by PBMC
cultures, detectable at 6 h of incubation, suggesting that GLP
may be the antigen that plays a pivotal role leading to TNF-
production by patients with leptospirosis. Monocyte-secreted
TNF- induces local inflammation, and, if present in sufficient
amounts in the circulation, it could unleash systemic inflam-
mation (38, 42). TNF- induces monocytes to secrete other
cytokines, such as IL-1, IL-6, and IL-8, all of which are essen-
tial in the control of infection but are also involved in tissue
lesions (35). Leptospirosis patients with higher TNF- have
been shown to have a poor prognosis (39).
In the present experiments, GLP also induced IL-10 produc-
tion in PBMC cultures, which showed a typically delayed ki-
netics compared to TNF- production. The latter can be de-
tected at as early as 6 hours of incubation, and its levels
decrease in the following 24 to 72 h. IL-10 was detectable at
low levels at 6 hours, increasing thereafter and reaching a
plateau at 48 to 72 h of incubation. This sequence of events
observed in vitro resembles cytokine patterns observed in pa-
tients with sepsis (9, 41). The induction of anti-inflammatory
cytokines, such as IL-10, may be essential to modulate the
inflammatory process, reducing tissue damage and stimulating
regeneration and healing. We have previously found the IL-
10/TNF- ratio to be higher among patients with less severe
leptospirosis (40).
Further evidence that GLP can induce cellular activation is
the increased ex vivo expression of CD69 on lymphocytes and
monocytes and of HLA-DR on monocytes. In the present
experiments, toxins were added to whole blood, preserving the
cell-toxin interaction microenvironment, like the case in vivo.
Resting lymphocytes present a low level of CD69 expression.
Nonspecific stimuli, such as phytohemagglutinin or phorbol
FIG. 1. TNF- kinetics and dose response after stimulation with GLP. LPS was used as positive control. PBMC were stimulated with either
S. enterica serovar Abortus Equi LPS or L. interrogans serovar Copenhageni GLP at the indicated doses and incubated for 72 h. Supernatants were
collected at the specified time-points and TNF- was measured by ELISA. Results are means  SDs from three experiments. Closed squares,
control; closed diamonds, LPS at 1 g/ml; open triangles, GLP at 0.3 g/ml; open squares, GLP at 0.03 g/ml; open diamonds, TLP at 0.003 g/ml.
For all GLP stimuli compared with controls, P  0.02; , P 	 0.05 compared to control; #, P 	 0.05 compared to 0.003 g/ml.
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ester, cytokines, and anti-CD69 antibodies, can induce an in-
crease in its expression, detected as early as 30 to 60 min after
incubation and sustained for more than 72 h. Activated cells
proliferate and secrete cytokines, producing a positive feed-
back effect on the lymphocyte response to the stimulus (28). In
our experiments, we were able to demonstrate increased CD69
expression on T lymphocytes within 6 h of incubation. In-
creased CD69 expression was also demonstrated on mono-
cytes. In these cells, CD69 acts as a signal transducer molecule.
Activation of monocytes through CD69 induces the secretion
of inflammatory mediators, such as prostaglandins E2 and F1
and leukotriene B4, and increased production of nitric oxide
(NO) (12). Increased intracellular NO production is essential
to control intracellular infection. However, excess NO secre-
tion in inflamed tissues results in cellular damage and vasodi-
latation. GLP-induced monocyte activation was further dem-
onstrated by the up-regulation of HLA-DR expression on cell
surface.
Vihn and coworkers (43) demonstrated that GLP extracted
from L. biflexa serovar Patoc had the same biological effects as
GLP extracted from pathogenic Leptospira, such as fibroblast
cytotoxicity, hemagglutination, and erythrocyte crenation. In
our hands, however, GLPp failed to induce the cellular acti-
vation observed with GLP under the same experimental con-
ditions. This discrepancy could be a result of different ap-
proaches used to detect cellular activation or differences in the
GLP extraction process. However, structural differences be-
tween GLP and GLPp may exist and could be related to the
pathophysiology of leptospirosis.
Other toxic factors, such as LPS, peptidoglycan, and phos-
pholipase, may also play a role in the pathogenesis of lepto-
spirosis, but their roles are not well established (11, 15, 22, 37,
44, 46). Lipoproteins are also potential toxic factors in lepto-
spirosis as well as in other spirochetal diseases. Lipoproteins
are recognized to be the most abundant proteins in spirochetes
and are involved in disease pathogenesis through their ability
to trigger the host inflammatory response (19). Expression of
leptospiral lipoproteins Lip L32 and Lip L41 was demon-
strated by immune histochemistry of kidney tissue following
infection with virulent Leptospira kirschneri (4, 19, 20). Trepo-
nemal and borrelial lipoproteins are capable of activating
monocytes in vitro, and cellular activation has been shown to
involve CD14 and Toll-like receptor 2 molecules (2, 18, 21, 34,
45).
In the present experiments GLP did not block LPSb bind-
ing to monocytes, suggesting that cellular activation may
follow a distinct pathway. GLP inhibits renal tubular cell
Na,K-ATPase and could have the same effect on monocytes.
FIG. 2. IL-10 kinetics and dose response after stimulation with GLP. LPS was used as positive control. PBMC were stimulated with either
S. enterica serovar Abortus Equi LPS or L. interrogans serovar Copenhageni GLP in the indicated doses and incubated for 72 h. Supernatants were
collected at the specified time points, and TNF- was measured by ELISA. Results are means  SDs from two experiments. Closed squares.
control; closed diamonds, LPS at 1 g/ml; open triangles, GLP at 0.3 g/ml; open squares, GLP at 0.03 g/ml; open diamonds, GLP at 0.003 g/ml.
For all GLP stimuli compared with controls, P  0.05; , P 	 0.05 compared to control.
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If this is true, it could be a mechanism involved in GLP-
induced TNF- secretion. In the PBMC, Na,K-ATPase in-
hibition induces proinflammatory cytokine secretion by
monocytes and abolishes lymphocyte proliferation, with no
influence on its early activation (7, 27, 30, 31). Foey and
coworkers (16) showed that blocking mononuclear cell Na,K-
ATPase with ouabain induced TNF- and IL-1 secretion.
Blocking of Na,K-ATPase, by its specific inhibitor bufalin, on
TPH-1 monocytic leukemic cell lines induces the secretion of
TNF- and IL-1 secondary to increased intracellular calcium
FIG. 3. CD69 expression on LPS- or GLP-stimulated lymphocytes and monocytes. Whole blood was incubated in the presence of LPS, GLP,
or medium alone for 6 h as described in Materials and Methods. CD69 is depicted as the percentage of positive cells acquired on the gate. Results
are means  SDs from five experiments with GLP and two experiments with GLPp. , P 	 0.05 compared to controls.
FIG. 4. HLA-DR expression on LPS- or GLP-stimulated monocytes. Whole blood was incubated in the presence of LPS, GLP, or medium
alone for 6 h as described in Materials and Methods. HLA-DR is depicted as geometric mean fluorescence intensity (GMFI). Results are means
 SDs from five experiments for GLP and two experiments for GLPp. , P 	 0.05 compared to controls.
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influx and activation of kinases and cytokine gene expression
(23). Taken together, the data suggest that inhibition of Na,K-
ATPase could be a possible mechanism of action for GLP.
In conclusion, GLP extracted from pathogenic L. interrogans
activates PBMC, as demonstrated by the secretion of TNF-
and IL-10 and expression of CD69 and HLA-DR. GLP ex-
tracted from nonpathogenic L. biflexa has no activation effect
under the same experimental conditions. GLP does not block
LPS binding to monocytes, suggesting that activation is in-
duced by a different pathway.
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